Correlation Between MediciNova and Immix Biopharma

Can any of the company-specific risk be diversified away by investing in both MediciNova and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MediciNova and Immix Biopharma, you can compare the effects of market volatilities on MediciNova and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Immix Biopharma.

Diversification Opportunities for MediciNova and Immix Biopharma

0.55

Correlation Coefficient

MediciNova  Immix Biopharma

Very weak diversification

The 3 months correlation between MediciNova and Immix is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of MediciNova i.e., MediciNova and Immix Biopharma go up and down completely randomly.

Pair Corralation between MediciNova and Immix Biopharma

Given the investment horizon of 90 days MediciNova is expected to generate 3.77 times less return on investment than Immix Biopharma. But when comparing it to its historical volatility, MediciNova is 1.63 times less risky than Immix Biopharma. It trades about 0.01 of its potential returns per unit of risk. Immix Biopharma is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  208.00  in Immix Biopharma on November 19, 2024 and sell it today you would lose (10.00) from holding Immix Biopharma or give up 4.81% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

MediciNova  vs.  Immix Biopharma

MediciNova

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, MediciNova may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Immix Biopharma

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Immix Biopharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Immix Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with MediciNova and Immix Biopharma

The main advantage of trading using opposite MediciNova and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.

The idea behind MediciNova and Immix Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.